S01 Benefits and Risks of Osteoporosis Therapies

Program: Symposia
Clinical Session
Friday, April 1, 2016: 9:45 AM-11:15 AM
Room 253 (BCEC)
Chair:
Nelson B Watts, MD, Mercy Health, Cincinnati, OH

Disclosures:
NBW: Advisory Group Member, Amgen, Speaker Bureau Member, Amgen, Advisory Group Member, Merck & Co., Scientific Board Member, Abbvie, Investigator, NPS, Ad Hoc Consultant, Sanofi.
9:45 AM
Rene Rizzoli, MD, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
Nothing to Disclose: RR
10:15 AM
Paul D Miller, MD, Colorado Center for Bone Research, Lakewood, CO
Nothing to Disclose: PDM
10:45 AM
Dennis M Black, PhD, Dept of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA
Nothing to Disclose: DMB
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire